ArticleEBioMedicine2020
Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease.
Yongfeng Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEBioMedicine2020
Yongfeng Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.